Tidemark’s ResMed RMD Stock Holding History

Tidemark’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95K	Hold	10	–	–	﹤0.01%	699
2026 Q1	$2.25K	Buy	+10	New	+$2.49K	﹤0.01%	646
2024 Q2	–	Sell	-771	Closed	-$153K	–	707
2024 Q1	$153K	Hold	771	–	–	0.09%	140
2023 Q4	$133K	Buy	+771	New	+$118K	0.08%	137

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tidemark's RMD Position: Q2 2026 in Review

Tidemark held its ResMed (RMD) position steady in Q2 2026 at 10 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #699.

Tidemark first reported a position in RMD in Q4 2023 and has held it in 4 quarters since. The position peaked at $153K in Q1 2024. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Tidemark held 10 shares of ResMed worth $1.95K as of Q2 2026.
Tidemark left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #699 holding.
Tidemark first reported a position in ResMed in Q4 2023 and has held it in 4 quarters since.
Tidemark's ResMed position peaked at $153K in Q1 2024.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.